Thanatat Boonmongkol
Overview
Explore the profile of Thanatat Boonmongkol including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bhidayasiri R, Boonmongkol T, Thongchuam Y, Phumphid S, Kantachadvanich N, Panyakaew P, et al.
PLoS One
. 2021 Jun;
16(6):e0252988.
PMID: 34086812
[This corrects the article DOI: 10.1371/journal.pone.0243051.].
2.
Bhidayasiri R, Boonmongkol T, Thongchuam Y, Phumphid S, Kantachadvanich N, Panyakaew P, et al.
PLoS One
. 2020 Dec;
15(12):e0243051.
PMID: 33264321
Background: The concerns of people with Parkinson's disease (PD) about their disease are often different from the objective clinical picture and subject to various influencing factors, including disease progression. Currently...
3.
Bhidayasiri R, Phokaewvarangkul O, Sakdisornchai K, Boonpang K, Chaudhuri K, Parsons J, et al.
Expert Rev Neurother
. 2020 May;
20(6):523-537.
PMID: 32421371
Introduction: The increasing global burden of Parkinson's disease (PD) poses a particular challenge for developing countries, such as Thailand, when delivering care to a geographically diverse populace with limited resources,...
4.
Bhidayasiri R, Panyakaew P, Trenkwalder C, Jeon B, Hattori N, Jagota P, et al.
Parkinsonism Relat Disord
. 2020 Mar;
72:82-87.
PMID: 32146380
An international panel of movement disorders specialists explored the views and perceptions of people with Parkinson's disease (PD) about their condition and its treatment, including the potential mismatch between the...
5.
Bhidayasiri R, Phokaewvarangkul O, Boonpang K, Boonmongkol T, Thongchuem Y, Kantachadvanich N, et al.
Clin Neuropharmacol
. 2019 Oct;
42(5):172-178.
PMID: 31567642
Objectives: A retrospective analysis at 2 specialist centers was undertaken to determine the long-term efficacy of subcutaneous apomorphine infusion (APO), rates and reasons for discontinuation, and factors that might contribute...